Condensed Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Total	ATM Agreement	Registered Direct Offering	Common Stock	Common Stock ATM Agreement	Common Stock Registered Direct Offering	Additional Paid-in Capital	Additional Paid-in Capital ATM Agreement	Additional Paid-in Capital Registered Direct Offering	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance as at beginning at Dec. 31, 2023	$ (115,437)			$ 3			$ 435,752			$ (1,538)	$ (549,654)
Balance as at beginning (in shares) at Dec. 31, 2023				24,166,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reverse recapitalization transaction, net of transaction costs and acquired liabilities	50,033			$ 2			50,031
Reverse recapitalization transaction, net of transaction costs and acquired liabilities (in shares)				21,667,000
Stock-based compensation	1,223						1,223
Foreign currency translation adjustment	1,064									1,064
Net income (loss)	757										757
Balance as at end at Mar. 31, 2024	(62,360)			$ 5			487,006			(474)	(548,897)
Balance as at end (in shares) at Mar. 31, 2024				45,833,000
Balance as at beginning at Dec. 31, 2023	(115,437)			$ 3			435,752			(1,538)	(549,654)
Balance as at beginning (in shares) at Dec. 31, 2023				24,166,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustment	1,772
Net income (loss)	(286)
Balance as at end at Jun. 30, 2024	(58,317)			$ 5			491,384			234	(549,940)
Balance as at end (in shares) at Jun. 30, 2024				46,679,000
Balance as at beginning at Mar. 31, 2024	(62,360)			$ 5			487,006			(474)	(548,897)
Balance as at beginning (in shares) at Mar. 31, 2024				45,833,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under common stock purchase agreement	3,388						3,388
Issuance of common stock under common stock purchase agreement (in shares)				679,000
Issuance of commitment shares in connection with common stock purchase agreement (in shares)				57,000
Issuance of common stock to underwriter	667						667
Issuance of common stock to underwriter (in shares)				110,000
Stock-based compensation	323						323
Foreign currency translation adjustment	708									708
Net income (loss)	(1,043)										(1,043)
Balance as at end at Jun. 30, 2024	(58,317)			$ 5			491,384			234	(549,940)
Balance as at end (in shares) at Jun. 30, 2024				46,679,000
Balance as at beginning at Dec. 31, 2024	$ (59,315)			$ 5			501,195			1,518	(562,033)
Balance as at beginning (in shares) at Dec. 31, 2024	47,987,000			47,987,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under common stock purchase agreement	$ 189						189
Issuance of common stock under common stock purchase agreement (in shares)				74,000
Issuance of common stock from option exercises	19						19
Issuance of common stock from option exercises (in shares)				173,000
Release of vested restricted stock units (in shares)				19,000
Shares withheld related to net share settlement of restricted stock units				(6,000)
Shares withheld related to net share settlement of restricted stock units	(11)						(11)
Stock-based compensation	511						511
Foreign currency translation adjustment	(51)									(51)
Net income (loss)	(6,968)										(6,968)
Balance as at end at Mar. 31, 2025	(65,626)			$ 5			501,903			1,467	(569,001)
Balance as at end (in shares) at Mar. 31, 2025				48,247,000
Balance as at beginning at Dec. 31, 2024	$ (59,315)			$ 5			501,195			1,518	(562,033)
Balance as at beginning (in shares) at Dec. 31, 2024	47,987,000			47,987,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock from option exercises (in shares)	187,146
Foreign currency translation adjustment	$ (1,743)
Net income (loss)	(20,506)
Balance as at end at Jun. 30, 2025	$ (69,976)			$ 6			512,782			(225)	(582,539)
Balance as at end (in shares) at Jun. 30, 2025	55,784,000			55,784,000
Balance as at beginning at Mar. 31, 2025	$ (65,626)			$ 5			501,903			1,467	(569,001)
Balance as at beginning (in shares) at Mar. 31, 2025				48,247,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under common stock purchase agreement	1	$ 471	$ 9,894			$ 1	1	$ 471	$ 9,893
Issuance of common stock under common stock purchase agreement (in shares)		297,891		1,000	298,000	7,006,000
Issuance of common stock from option exercises	2						2
Issuance of common stock from option exercises (in shares)				14,000
Release of vested restricted stock units (in shares)				218,000
Stock-based compensation	512						512
Foreign currency translation adjustment	(1,692)									(1,692)
Net income (loss)	(13,538)										(13,538)
Balance as at end at Jun. 30, 2025	$ (69,976)			$ 6			$ 512,782			$ (225)	$ (582,539)
Balance as at end (in shares) at Jun. 30, 2025	55,784,000			55,784,000